Observational studyInternational journal of urology : official journal of the Japanese Urological Association2024

Real-world outcomes of avelumab plus axitinib as first-line therapy in patients with advanced renal cell carcinoma in Japan: A multicenter, retrospective, observational study (J-DART).

Taigo Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.